SKI Market

Indian Indices

Nifty

26,186.45 152.70
(0.59%)

Sensex

85,712.37 447.05
( 0.52%)

Bank Nifty

59,777.20 488.50
( 0.82%)

Nifty IT

38,703.65 343.40
( 0.90%)

Global Indices

Nasdaq

47,981.01 109.07
(0.23%)

Dow Jones

6,892.33 14.21
(0.21%)

Hang Seng

50,440.45 -587.97
(-1.15%)

Nikkei 225

9,667.01 -43.86
(-0.45%)

Forex

USD-INR

89.99 -0.14
(-0.16%)

EUR-INR

104.92 -0.11
(-0.11%)

GBP-INR

120.05 0.29
(0.24%)

JPY-INR

0.58 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

92.66

433067.97

EPS(TTM)

Face Value()

Div & Yield %

19.48

0.89

Back

sun pharmaceuticals industries ltd

Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter

Nov 05,2025

Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	14405.22	13264.22	9
OPM %	31.43	29.70	-
PBDT	4897.11	4223.79	16
PBT	4167.61	3597.88	16
NP	3117.95	3040.16	3

26,186.45 152.70 (0.59%)

85,712.37 447.05 ( 0.52%)

59,777.20 488.50 ( 0.82%)

38,703.65 343.40 ( 0.90%)

47,981.01 109.07 (0.23%)

6,892.33 14.21 (0.21%)

50,440.45 -587.97 (-1.15%)

9,667.01 -43.86 (-0.45%)

89.99 -0.14 (-0.16%)

104.92 -0.11 (-0.11%)

120.05 0.29 (0.24%)

0.58 0.00 (0.11%)